ATE135909T1 - Verfahren zur behandlung von akne - Google Patents

Verfahren zur behandlung von akne

Info

Publication number
ATE135909T1
ATE135909T1 AT89905844T AT89905844T ATE135909T1 AT E135909 T1 ATE135909 T1 AT E135909T1 AT 89905844 T AT89905844 T AT 89905844T AT 89905844 T AT89905844 T AT 89905844T AT E135909 T1 ATE135909 T1 AT E135909T1
Authority
AT
Austria
Prior art keywords
treating acne
nodulocystic
alleviated
cis
humans
Prior art date
Application number
AT89905844T
Other languages
English (en)
Inventor
Gary L Peck
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE135909T1 publication Critical patent/ATE135909T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203Retinoic acids ; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT89905844T 1988-04-26 1989-04-26 Verfahren zur behandlung von akne ATE135909T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18626088A 1988-04-26 1988-04-26

Publications (1)

Publication Number Publication Date
ATE135909T1 true ATE135909T1 (de) 1996-04-15

Family

ID=22684246

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89905844T ATE135909T1 (de) 1988-04-26 1989-04-26 Verfahren zur behandlung von akne

Country Status (7)

Country Link
US (1) US5698593A (de)
EP (1) EP0414772B1 (de)
AT (1) ATE135909T1 (de)
AU (1) AU627733B2 (de)
DE (1) DE68926115T2 (de)
IL (1) IL90069A (de)
WO (1) WO1989010128A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6339107B1 (en) 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
US20030215493A1 (en) * 2002-04-30 2003-11-20 Patel Pravin M. Composition and method for dermatological treatment
US20110142922A1 (en) * 2002-04-30 2011-06-16 Ferndale Ip, Inc. Stabilized composition and method for dermatological treatment
DK1723278T3 (da) * 2004-03-10 2007-12-27 Saertex Gmbh & Co Kg Multiaksialt kompleks
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) * 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
EP1971331A2 (de) * 2005-12-09 2008-09-24 Basilea Pharmaceutica AG 4-oxo-(iso)tretinoin zur topischen behandlung von schweren dermatologischen erkrankungen
US20070254858A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
US20070254025A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en) 2013-01-09 2013-12-24 NU Technology, LLC Dermatological cream with natural ingredients base

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US3882244A (en) * 1971-12-13 1975-05-06 Univ California Method of treating acne with a c{hd 20 {b acid
US3932665A (en) * 1974-04-05 1976-01-13 Scott Eugene J Van Process for the treatment of acne vulgaris utilizing retinal
US3934028A (en) * 1974-04-22 1976-01-20 The Regents Of The University Of California Acne and psoriasis treatment with retinoic acid analogs
US4322438A (en) * 1979-08-06 1982-03-30 United States Of America Method for the use of orally administered 13-cis-retinoic acid in the treatment of acne
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
CH658387A5 (de) * 1984-04-02 1986-11-14 Hoffmann La Roche Pharmazeutische praeparate.
US4545977A (en) * 1985-01-11 1985-10-08 G. D. Searle & Co. Compositions and methods for treating severe acne with isotretinoin
US4677120A (en) * 1985-07-31 1987-06-30 Molecular Design International Topical prodrugs for treatment of acne and skin diseases

Also Published As

Publication number Publication date
EP0414772B1 (de) 1996-03-27
WO1989010128A1 (en) 1989-11-02
DE68926115D1 (de) 1996-05-02
AU3569089A (en) 1989-11-24
DE68926115T2 (de) 1996-10-02
EP0414772A4 (en) 1991-07-03
AU627733B2 (en) 1992-09-03
EP0414772A1 (de) 1991-03-06
IL90069A (en) 1994-04-12
US5698593A (en) 1997-12-16

Similar Documents

Publication Publication Date Title
ATE135909T1 (de) Verfahren zur behandlung von akne
ATE69378T1 (de) Pharmazeutische zusammensetzungen.
UA41502C2 (uk) Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
RU93004484A (ru) Производные пиразола, способ их получения и содержащие их фармацевтические композиции
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
DE3852877D1 (de) Pharmazeutische Zubereitungen zur Verhütung von Arzneimitteltoleranz.
DE69329400D1 (de) L-Dopa Ester enthaltende Zusammensetzung
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE133859T1 (de) Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen
KR910005858A (ko) 지방산 요법
DE69325236D1 (de) Pharmazeutische Zusammensetzungen enthaltend Urodeoxycholicsäure
DE69632396D1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
ES2052000T3 (es) Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
JPS6468320A (en) Remedy for psychotic disease or like and therapeutical solution
FI891357A0 (fi) Menetelmä valmistaa salisyylihappopitoista ainetta hilseileviä ihosairauksia vastaan
TW325404B (en) Pharmaceutical composition for the safe administration of fatty acids the invention relates to a pharmaceutical composition for the safe administration of fatty acids which is useful in the treatment of cancer, viral infections and other disorders.
IT8748404A0 (it) O-alcanoil derivati dell'acido 3ammino-2-idrossipropansolfonico adattivita'anticonvulsivante e loro composizioni farmaceutiche per il trattamento terapeutico dell'epilessia
DE69315162D1 (de) Verwendung von L-Carnitine und Acyl-L-Carnitinen zur Behandlung von Patienten die an AIDS-verwandten Syndromen leiden und von asymptomatischen HIV-seropositiven Patienten
ES2006121A6 (es) Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
EP0383481A3 (de) Bukkale Anästhetika
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
RU93016030A (ru) Лекарственное средство, стимулирующее гранулоцитарный росток кроветворения при цитостатических миелодепрессиях
RU93042731A (ru) Способ лечения постнатальной гипотрофии поросят

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties